These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1481791)

  • 61. Digital Rx.
    Schneider P
    Healthc Inform; 1998 Feb; 15(2):40-2. PubMed ID: 10177681
    [No Abstract]   [Full Text] [Related]  

  • 62. Ohio hospital formularies: an analysis of structure, process, and outcome.
    Parrish RH; Berger BA
    Hosp Pharm; 1985 Aug; 20(8):600-3, 606-11. PubMed ID: 10289647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. How you can help to avoid medication errors in your hospital pharmacy.
    Spooner LE; May JR
    Pharm Times; 1987 May; 53(5):101-5. PubMed ID: 10282423
    [No Abstract]   [Full Text] [Related]  

  • 64. Clinical considerations and costs associated with formulary conversion from tobramycin to gentamicin.
    Green ER; Chrymko MM; Rozek SL; Kitrenos JG
    Am J Hosp Pharm; 1989 Apr; 46(4):714-9. PubMed ID: 2719049
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The drug list of the American Hospital Formulary Service].
    BOETZKES H
    Pharm Prax; 1961; 7():114-7. PubMed ID: 13870518
    [No Abstract]   [Full Text] [Related]  

  • 67. A dangerous error in the dilution of 25 percent albumin.
    Steinmuller DR
    N Engl J Med; 1998 Apr; 338(17):1226-7. PubMed ID: 9556391
    [No Abstract]   [Full Text] [Related]  

  • 68. HOSPITAL FORMULARIES: HISTORY, PHILOSOPHY, IMPLEMENTATION.
    SIMON GJ
    Hosp Top; 1965 Apr; 43():75-9. PubMed ID: 14265849
    [No Abstract]   [Full Text] [Related]  

  • 69. The current status of hospital formularies.
    CADMUS RR
    Hosp Prog; 1962 Mar; 43():106-7. PubMed ID: 13875485
    [No Abstract]   [Full Text] [Related]  

  • 70. Nonformulary drug requests as a guide in formulary system management.
    Hailemeskel B; Kelvas M
    Am J Health Syst Pharm; 1999 Apr; 56(8):818, 820. PubMed ID: 10326618
    [No Abstract]   [Full Text] [Related]  

  • 71. A PHYSICIAN APPRAISES THE FORMULARY SYSTEM.
    PELLEGRINO ED
    Hospitals; 1965 Jan; 39():77-80. PubMed ID: 14219002
    [No Abstract]   [Full Text] [Related]  

  • 72. Freedom to prescribe--in ignorance.
    Br Med J; 1978 Jun; 1(6127):1573-4. PubMed ID: 656816
    [No Abstract]   [Full Text] [Related]  

  • 73. Pharmaceutical promotion and physician requests to hospital formularies.
    Rubin PH
    JAMA; 1994 Aug; 272(5):355. PubMed ID: 8028162
    [No Abstract]   [Full Text] [Related]  

  • 74. [Characteristics of the prescriptions of Perm Province Clinical Hospital].
    Selezneva VT; Seklitskaia AM
    Farmatsiia; 1977; 26(5):56-9. PubMed ID: 144068
    [No Abstract]   [Full Text] [Related]  

  • 75. Drug dosing in pediatric intensive care and in pediatrics in general.
    Degraeuwe PL; van der Zanden RW
    Pediatr Crit Care Med; 2011 Jul; 12(4):483-4; author reply 484-5. PubMed ID: 21799320
    [No Abstract]   [Full Text] [Related]  

  • 76. HOW A UTILIZATION COMMITTEE CAN CONTRIBUTE TO ADMINISTRATION.
    LONDON M
    Hospitals; 1964 Jul; 38():32-5;98. PubMed ID: 14155235
    [No Abstract]   [Full Text] [Related]  

  • 77. Robert's rules of unparliamentary procedure. II. The treatment of pharmacoplethora.
    ROSE I
    Can Med Assoc J; 1963 Jul; 89(1):27. PubMed ID: 13974789
    [No Abstract]   [Full Text] [Related]  

  • 78. Local formularies--the way ahead.
    Lancet; 1986 Nov; 2(8515):1078-9. PubMed ID: 2877232
    [No Abstract]   [Full Text] [Related]  

  • 79. Selection of essential drugs. Standardized supply of essential drugs in Ghana. 1.
    Hogerzeil HV
    Trop Doct; 1986 Jul; 16(3):113-6. PubMed ID: 3765094
    [No Abstract]   [Full Text] [Related]  

  • 80. The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information.
    Fijn R; de Vries CS; Engels SA; Brouwers JR; de Blaey CJ; de Jong-van den Berg LT
    Pharm World Sci; 1999 Jun; 21(3):120-6. PubMed ID: 10427581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.